Multiantigen T-Cell Hybridizers: A Two-Component T-Cell-Activating Therapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Multiantigen T-Cell Hybridizers: A Two-Component T-Cell-Activating Therapy

Published:2024-08-16 Issue:34 Volume:18 Page:23341-23353
ISSN:1936-0851
Container-title:ACS Nano
language:en
Short-container-title:ACS Nano

Author:

Gambles M. Tommy¹²,Li Shannuo¹²,Kendell Isaac³,Li Jiahui¹²,Sborov Douglas⁴,Shami Paul⁴,Yang Jiyuan¹²,Kopeček Jindřich¹²³^ORCID

Affiliation:

1. Center for Controlled Chemical Delivery, University of Utah, Salt Lake City, Utah 84112, United States

2. Department of Molecular Pharmaceutics, University of Utah, Salt Lake City, Utah 84112, United States

3. Department of Biomedical Engineering, University of Utah, Salt Lake City, Utah 84112, United States

4. Huntsman Cancer Institute, University of Utah, Salt Lake City ,Utah 84112, United States

Funder

National Cancer Institute

Huntsman Cancer Institute, University of Utah

Publisher

American Chemical Society (ACS)

Link

https://pubs.acs.org/doi/pdf/10.1021/acsnano.4c06500

Reference50 articles.

1. Bispecific Antibodies in Cancer Immunotherapy: A Novel Response to an Old Question

2. The landscape of bispecific T cell engager in cancer treatment

3. Bispecific Antibodies: A Smart Arsenal for Cancer Immunotherapies

4. Bispecific, T-Cell-Recruiting Antibodies in B-Cell Malignancies

5. A novel co-culture assay to assess anti-tumor CD8+ T cell cytotoxicity via luminescence and multicolor flow cytometry

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP